Desmosterol in human nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Desmosterol in human nonalcoholic steatohepatitis

Published:2013-07-29 Issue:3 Volume:58 Page:976-982
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Simonen Marko,Männistö Ville¹,Leppänen Joel²,Kaminska Dorota²,Kärjä Vesa³,Venesmaa Sari⁴,Käkelä Pirjo⁴,Kuusisto Johanna¹,Gylling Helena,Laakso Markku¹,Pihlajamäki Jussi

Affiliation:

1. Department of Medicine; University of Eastern Finland and Kuopio University Hospital; Finland

2. Institute of Public Health and Clinical Nutrition; University of Eastern Finland; Finland

3. Department of Pathology; University of Eastern Finland and Kuopio University Hospital; Finland

4. Department of Surgery; University of Eastern Finland and Kuopio University Hospital; Finland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26342/fullpdf

Reference45 articles.

1. Nonalcoholic fatty liver disease;Adams;Ann Epidemiol,2007

2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

3. Liver fat in the metabolic syndrome;Kotronen;J Clin Endocrinol Metab,2007

4. Non-alcoholic fatty liver disease from pathogenesis to management: an update;Musso;Obes Rev,2010

5. Molecular mediators of hepatic steatosis and liver injury;Browning;J Clin Invest,2004

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shaping immune landscape of colorectal cancer by cholesterol metabolites;EMBO Molecular Medicine;2024-01-02

2. IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids;Cell Reports Medicine;2024-01

3. Oxymatrine Alleviates High-Fat-High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through an Untargeted Metabonomics Study;Diabetes, Metabolic Syndrome and Obesity;2023-12

4. Mendelian randomization to evaluate the causal relationship between liver enzymes and the risk of six specific bone and joint-related diseases;Frontiers in Immunology;2023-08-16

5. Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation;EMBO Molecular Medicine;2023-06-26